IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Mime-Version:
1.0
Sender:
Information and Referral and Internet Sightings <[log in to unmask]>
Subject:
news byte: Haldol warnings
From:
Sylvia Caras <[log in to unmask]>
Date:
Mon, 24 Sep 2007 09:36:15 -0700
Content-Type:
text/plain; charset=us-ascii; format=flowed; x-avg-checked=avg-ok-42F3556E
Reply-To:
[log in to unmask]
Parts/Attachments:
text/plain (11 lines) 
 From PharmaLive News Archive - Sep 17, 2007

Johnson and Johnson and FDA informed healthcare professionals that 
the WARNINGS section of the prescribing information for haloperidol 
has been revised to include a new Cardiovascular subsection regarding 
cases of sudden death, QT prolongation and Torsades de Pointes(TdP) 
in patients treated with haloperidol, especially when given 
intravenously, or at doses higher than recommended.

www.peoplewho.org

ATOM RSS1 RSS2